Understanding the Link Between Hypertension and End-Stage Renal Disease

About this course

Often regarded in the medical community as a silent killer, recent data has revealed that uncontrolled hypertension is the primary reason for end-stage renal disease (ESRD), the last phase of chronic kidney disease. Understanding the link between hypertension and ESRD is crucial for healthcare professionals, not only for treatment but also for patient education, monitoring, and management. This course aims to provide an overview of hypertension and ESRD, exploring their definitions, underlying physiology, and the pathophysiology that connects them.

Learning objectives

• Define hypertension as described by The American College of Cardiology and the American Heart Association.
• Review the pathophysiology associated with hypertension, uncontrolled hypertension, and hypertensive crisis and their risk factors.
• Review the pathophysiology associated with end stage renal disease, and how disease progression can be influenced hypertension.
• Review dialysis types and transplant options for patients diagnosed with end stage renal disease.
• Comprehend antihypertensive medications commonly prescribed for patients with kidney failure.

Course outline

13 sections · finish in any order across devices

1. 1

   Introduction

   Hypertension is a rampant health condition that affects millions of people worldwide. According to the World Health Organization, approximately 1.39 billion of the world's adult population, aged 30-79 years, have hypertension. In the US, approximately 116 million individuals have hypertension.25 Oft

   4 min

2. 2

   Hypertension Pathophysiology

   Hypertension (HTN), or high blood pressure as it is more commonly known, is a chronic medical condition characterized by elevated pressure exerted by the blood against the walls of arteries. It is typically measured by two values:26.

   5 min

3. 3

   Uncontrolled Hypertension

   Uncontrolled hypertension is a condition where blood pressure remains persistently elevated above 140/90 mmHg despite the use of antihypertensive medications, diet changes, and lifestyle modifications.10 There are several factors that can contribute to uncontrolled hypertension, including unhealthy

   4 min

4. 4

   Risks Associated with Uncontrolled Hypertension

   Uncontrolled hypertension, or persistently high blood pressure that is not effectively managed poses significant risks to numerous body systems, including the cardiovascular, neurological, ocular, metabolic, endocrine, and renal systems.23

   4 min

5. 5

   Management of Hypertensive Crisis

   A hypertensive crisis refers to a severe elevation in blood pressure that poses an immediate threat to organ function and patient health.19 It is characterized by systolic blood pressure readings greater than 180 mmHg, diastolic blood pressure readings greater than 120 mmHg, or both.30 Hypertensive

   4 min

6. 6

   End Stage Renal Disease Pathophysiology

   End-stage renal disease (ESRD) is the final phase of chronic kidney disease. 18 In ESRD, the nephrons, the functional elements of the kidneys responsible for filtration, have suffered extensive damage and have lost nearly all their ability to maintain the body's balance of fluids, electrolytes, and

   4 min

7. 7

   Mechanisms of Hypertension Leading to Kidney Failure

   Chronic hypertension is the second most common cause of both chronic kidney disease and failure.5 The precise pathophysiology of kidney damage induced by hypertension involves various mechanisms.6 The sustained elevation of blood pressure places excessive strain on the delicate structures of the kid

   4 min

8. 8

   Consequences of Kidney Failure

   Kidney failure has widespread effects on the body and can lead to serious metabolic, cardiovascular, hematologic, gastrointestinal, and neurological complications.15 Failing kidneys are unable to excrete excess fluid, leading to swelling in the face, ankles, legs, and feet. If left untreated, severe

   4 min

9. 9

   Kidney Transplantation

   Kidney transplantation involves the surgical implantation of a healthy kidney from a biocompatible donor into the recipient's body, effectively replacing the failed kidneys and restoring renal function.15 There are several transplant options available for individuals with ESRD. These include decease

   4 min

10. 10

    Dialysis Types

    There are two forms of dialysis:4

    4 min

11. 11

    Antihypertensive Medications Options

    Antihypertensive medications commonly prescribed for patients with kidney failure include angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers, beta-blockers, and diuretics.28 Angiotensin-converting enzyme inhibitors, such as lisinopril an

    4 min

12. 12

    Nursing Considerations

    When caring for patients with hypertension and end-stage renal disease (ESRD), nurses play a crucial role in providing holistic care to promote optimal health outcomes and quality of life.25 Nursing considerations encompass various aspects of care, including coordination, treatment management, conti

    4 min

13. 13

    Conclusion

    Examining the connection between hypertension and end-stage renal disease (ESRD) reveals a compelling cycle of mutual influence. Hypertension not only stands as a precursor to ESRD, but when uncontrolled, further damages the delicate structures of the kidney. This perpetuates the progression of kidn

    4 min

This course satisfies

Requirement summaries come from our state requirement records. Always confirm details with your board before you renew.

References and resources

• “Annual Data Report.” USRDS, usrds-adr.niddk.nih.gov/2023.
• Arasu, Rohan, et al. “Overview of Hemodialysis Access and Assessment.” Canadian Family Physician, vol. 68, no. 8, Aug. 2022, pp. 577–582, https://doi.org/10.46747/cfp.6808577.
• Bhandari, Simran K., et al. “Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System.” American Journal of Nephrology, vol. 53, no. 1, 2022, pp. 32–40, https://doi.org/10.1159/000520466.
• Braun, Michael M, and Maurice Khayat. “Kidney Disease: End-Stage Renal Disease.” FP Essentials, vol. 509, 1 Oct. 2021, pp. 26–32, europepmc.org/article/med/34643362. Accessed 15 May 2024.
• Centers for Disease Control and Prevention. “Chronic Kidney Disease in the United States, 2021.” Www.cdc.gov, 9 Mar. 2021, www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html.
• Cherfane, Michelle, et al. “Risk Factors for Uncontrolled Blood Pressure among Individuals with Hypertension on Treatment: The CONSTANCES Population-Based Study.” International Journal of Epidemiology, vol. 53, no. 2, 14 Feb. 2024, p. dyae027, pubmed.ncbi.nlm.nih.gov/38412540/, https://doi.org/10.1093/ije/dyae027. Accessed 15 May 2024.
• Daghbouche-Rubio, Nuria, et al. “Vascular Smooth Muscle Ion Channels in Essential Hypertension.” Frontiers in Physiology, vol. 13, 23 Sept. 2022, https://doi.org/10.3389/fphys.2022.1016175.
• De Bhailis, Áine M., and Philip A. Kalra. “Hypertension and the Kidneys.” British Journal of Hospital Medicine (London, England: 2005), vol. 83, no. 5, 2 May 2022, pp. 1–11, pubmed.ncbi.nlm.nih.gov/35653320/, https://doi.org/10.12968/hmed.2021.0440.
• Ekman, Natalia, et al. “What We Know about and What Is New in Primary Aldosteronism.” International Journal of Molecular Sciences, vol. 25, no. 2, 11 Jan. 2024, pp. 900–900, www.ncbi.nlm.nih.gov/pmc/articles/PMC10815558/, https://doi.org/10.3390/ijms25020900.
• Farhadi, Fariba, et al. Prevalence of Uncontrolled Hypertension and Its Associated Factors in 50–74 Years Old Iranian Adults: A Population-Based Study. Vol. 23, no. 1, 24 June 2023, https://doi.org/10.1186/s12872-023-03357-x.
• Fernandez, Cornelius J., et al. “Endocrine Hypertension: The Urgent Need for Greater Global Awareness.” TouchREVIEWS in Endocrinology, vol. 19, no. 2, 1 Nov. 2023, pp. 31–41, pubmed.ncbi.nlm.nih.gov/38187076/, https://doi.org/10.17925/EE.2023.19.2.11.
• Flack, John M., and Bemi Adekola. “Blood Pressure and the New ACC/AHA Hypertension Guidelines.” Trends in Cardiovascular Medicine, vol. 30, no. 3, Apr. 2020, pp. 160–164, https://doi.org/10.1016/j.tcm.2019.05.003.
• Fuchs, Flávio D., and Paul K. Whelton. “High Blood Pressure and Cardiovascular Disease.” Hypertension, vol. 75, no. 2, 23 Dec. 2019, pp. 285–292, www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.119.14240, https://doi.org/10.1161/HYPERTENSIONAHA.119.14240.
• Gathiram, Premjith, et al. “The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: A Review.” Current Hypertension Reports, vol. 23, no. 4, 2021, www.ncbi.nlm.nih.gov/pmc/articles/PMC7993901/, https://doi.org/10.1007/s11906-021-01134-9. Accessed 4 May 2021.
• Gusev, Evgenii, et al. “The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation.” International Journal of Molecular Sciences, vol. 22, no. 21, 23 Oct. 2021, p. 11453, https://doi.org/10.3390/ijms222111453.
• Hreńczuk, Marta. “Therapeutic Relationship Nurse–Patient in Hemodialysis Therapy.” Nursing Forum, vol. 56, no. 3, 5 May 2021, pp. 579–586, https://doi.org/10.1111/nuf.12590.
• Kiberd, Bryce A., et al. “Optimal Sequencing of Deceased Donor and Live Donor Kidney Transplant among Pediatric Patients with Kidney Failure.” JAMA Network Open, vol. 5, no. 1, 6 Jan. 2022, p. e2142331, https://doi.org/10.1001/jamanetworkopen.2021.42331. Accessed 1 Mar. 2022.
• Kim, Chang Seong, et al. “Cumulative Hypertension Burden and Risk of End-Stage Renal Disease.” Hypertension Research, vol. 44, no. 12, 19 Aug. 2021, pp. 1652–1661, https://doi.org/10.1038/s41440-021-00723-0. Accessed 28 Mar. 2023.
• Krishnarao, Krithika, and Selim R. Krim. “July 2023 - Volume 38 - Issue 4 : Current Opinion in Cardiology.” Journals.lww.com, journals.lww.com/co-cardiology/abstract/2023/07000/hypertensive_crisis__diagnosis. Accessed 15 May 2024.
• Li, An-le, et al. “Risk Probability and Influencing Factors of Stroke in Followed-up Hypertension Patients.” BMC Cardiovascular Disorders, vol. 22, no. 1, 24 July 2022, p. 328, pubmed.ncbi.nlm.nih.gov/35871681/, https://doi.org/10.1186/s12872-022-02780-w.
• Ma, Jun, et al. “Signaling Pathways in Vascular Function and Hypertension: Molecular Mechanisms and Therapeutic Interventions.” Signal Transduction and Targeted Therapy, vol. 8, no. 1, 20 Apr. 2023, pp. 1–30, www.nature.com/articles/s41392-023-01430-7, https://doi.org/10.1038/s41392-023-01430-7.
• McGill, Rita L., and Daniel E. Weiner. “Dialysate Composition for Hemodialysis: Changes and Changing Risk.” Seminars in Dialysis, vol. 30, no. 2, 1 Mar. 2017, pp. 112–120, www.ncbi.nlm.nih.gov/pmc/articles/PMC7645386/, https://doi.org/10.1111/sdi.12573.
• Meher, Meghanad, et al. “Risk Factors Associated with Hypertension in Young Adults: A Systematic Review.” Cureus, vol. 15, no. 4, 12 Apr. 2023, https://doi.org/10.7759/cureus.37467.
• Merrill, John P. Dialysis versus Transplantation in the Treatment of End-Stage Renal Disease. Vol. 29, no. 1, 1 Jan. 1978, pp. 343–358, https://doi.org/10.1146/annurev.me.29.020178.002015. Accessed 17 May 2023.
• Mills, Katherine T., et al. “The Global Epidemiology of Hypertension.” Nature Reviews Nephrology, vol. 16, no. 4, 5 Feb. 2020, pp. 223–237, https://doi.org/10.1038/s41581-019-0244-2.
• Oparil, Suzanne, et al. “Hypertension.” Nature Reviews Disease Primers, vol. 4, no. 4, 22 Mar. 2019, pp. 1–48, www.ncbi.nlm.nih.gov/pmc/articles/PMC6477925/, https://doi.org/10.1038/nrdp.2018.14.
• Pham, Thomas A., et al. “Kidney Paired Exchange and Desensitization: Strategies to Transplant the Difficult to Match Kidney Patients with Living Donors.” Transplantation Reviews, vol. 31, no. 1, Jan. 2017, pp. 29–34, https://doi.org/10.1016/j.trre.2017.01.003. Accessed 27 Apr. 2019.
• Pugh, Dan, et al. “Management of Hypertension in Chronic Kidney Disease.” Drugs, vol. 79, no. 4, 13 Feb. 2019, pp. 365–379, www.ncbi.nlm.nih.gov/pmc/articles/PMC6422950/, https://doi.org/10.1007/s40265-019-1064-1.
• Raja, Adarsh, et al. “Temporal Trends in Hypertension Related End Stage Renal Disease Mortality Rates: An Analysis of Gender, Race/Ethnicity, and Geographic Disparities in the United States.” Frontiers in Nephrology, vol. 3, 15 Jan. 2024, www.ncbi.nlm.nih.gov/pmc/articles/PMC10823365/, https://doi.org/10.3389/fneph.2023.1339312. Accessed 22 Mar. 2024.
• Rattanaporn Chootong, et al. “Characteristics and Factors Associated with Hypertensive Crisis: A Cross-Sectional Study in Patients with Hypertension Receiving Care in a Tertiary Hospital.” Annals of Medicine and Surgery, vol. 85, no. 10, 7 Sept. 2023, pp. 4816–4823, www.ncbi.nlm.nih.gov/pmc/articles/PMC10552971/, https://doi.org/10.1097/ms9.0000000000001250.
• Rohan Mahabaleshwarkar, et al. “Prevalence and Correlates of Uncontrolled Hypertension, Persistently Uncontrolled Hypertension, and Hypertensive Crisis at a Healthcare System.” American Journal of Hypertension, vol. 36, no. 12, 28 Aug. 2023, pp. 667–676, https://doi.org/10.1093/ajh/hpad078. Accessed 6 Dec. 2023.
• Sierra, Cristina. “Hypertension and the Risk of Dementia.” Frontiers in Cardiovascular Medicine, vol. 7, no. 5, 31 Jan. 2020, https://doi.org/10.3389/fcvm.2020.00005.
• Smith, Dustin K., et al. “Managing Hypertension Using Combination Therapy.” American Family Physician, vol. 101, no. 6, 15 Mar. 2020, pp. 341–349, www.aafp.org/pubs/afp/issues/2020/0315/p341.html.
• Teitelbaum, Isaac. “Peritoneal Dialysis.” New England Journal of Medicine, vol. 385, no. 19, 4 Nov. 2021, pp. 1786–1795, https://doi.org/10.1056/nejmra2100152.
• Vardulaki, K. A., et al. “Quantifying the Risks of Hypertension, Age, Sex and Smoking in Patients with Abdominal Aortic Aneurysm.” British Journal of Surgery, vol. 87, no. 2, Feb. 2000, pp. 195–200, https://doi.org/10.1046/j.1365-2168.2000.01353.x.
• Zhang, Yin, et al. “Long-Term Use of Antihypertensive Medications, Hypertension and Colorectal Cancer Risk and Mortality: A Prospective Cohort Study.” British Journal of Cancer, vol. 127, no. 11, 22 Sept. 2022, pp. 1974–1982, https://doi.org/10.1038/s41416-022-01975-4. Accessed 20 Mar. 2023.

Update history